Search For "pharma"
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate C
Updated : 5 years, 9 months ago IST
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
Read More
Preventive healthcare is more than important in current times
Updated : 5 years, 9 months ago IST
New Delhi [India] June 19 (ANI/Mediawire): The only thing constant in this world is "Change". Keeping that in mind KOPRAN Pharmaceutical is evolving in tune with changing times; Kopran is refocusing to meet newly raised great demands of the preventive healthcare industry.
Read More
Cipla expands partnership with Roche Pharma to improve access for oncology
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 18 (ANI): Pharmaceutical majors Cipla and Roche Products India said on Thursday they have entered into an agreement to provide better access to innovative medicines for patients in India.
Read More
Operation of website 'promoting e-pharmacies' suspended: Centre tells Delh
Updated : 5 years, 9 months ago IST
New Delhi [India], June 17 (ANI): The Central government has submitted before the Delhi High Court that the operation of the Aarogya Setu Mitr website, which is said to have been promoting and acting as a marketing tool for e-pharmacies, has been suspended.
Read More
Equity indices trade lower on profit-booking, Sun Pharma top loser
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 11 (ANI): Equity benchmark indices traded lower during early hours on Thursday as traders booked profit across counters, a day after the US Federal Reserve said that it sees interest rates near zero through 2022.
Read More
Cipla to acquire 21.85 pc stake in GoApptiv, expand reach in small towns
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 10 (ANI): Pharmaceutical major Cipla said on Wednesday it will acquire 21.85 per cent stake in GoApptiv to expand the reach of its key brands in tier three plus towns.
Read More
A2A Pharmaceuticals collaborates with LAXAI Life Sciences to Co-develop SA
Updated : 5 years, 9 months ago IST
Hyderabad (Telangana) [India], June 9 (ANI/PRNewswire): A2A Pharmaceuticals, a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents announces today an agreement to co-develop SARS-CoV-2 Main Proteases inhibitors for the treatment of
Read More
Equity gauges up in early trading, pharma stocks gain
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 9 (ANI): Equity benchmark indices gained during early hours on Tuesday in volatile trading with pharma stocks leading the rally.
Read More
JNU's staffer tests positive for COVID-19, varsity asks students to exerci
Updated : 5 years, 9 months ago IST
New Delhi [India], June 7 (ANI): One staff member, pharmacist, of the Jawaharlal Nehru University (JNU) Health Centre has tested positive for COVID-19, according to the varsity administration on Sunday.
Read More
Atrimed Pharma launch 'Plant Science' range hand sanitiser to join the fig
Updated : 5 years, 9 months ago IST
Bengaluru (Karnataka) [India] June 5 (ANI/NewsVoir): Bengaluru-based Atrimed Pharma - a pioneer in developing scientifically-tested plant-based medication, today announced its efforts to join the fight against COVID-19, with the launch of a company-subsidized herbal hand sanitiser.
Read More
Sun Pharma initiates phase two clinical trial on AQCH as potential treatme
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
Read More
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More